Search research articles
Contact Us
Filters
Showing results (141-150 of 151) with videos related to
Page
of 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2012
Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era
Philippe A Cassier, Elena Fumagalli, Piotr Rutkowski, et al.
The Lancet. Oncology
|
June 5, 2019
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial
Ian Judson, James P Morden, Lucy Kilburn, et al.
The Lancet. Oncology
|
March 13, 2014
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Ian Judson, Jaap Verweij, Hans Gelderblom, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 4, 2023
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022
Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2015
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
Nathalie Gaspar, Douglas S Hawkins, Uta Dirksen, et al.
The Lancet. Oncology
|
August 9, 2016
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
Mandy L Ballinger, David L Goode, Isabelle Ray-Coquard, et al.
Nature Communications
|
June 29, 2023
The proteomic landscape of soft tissue sarcomas
Jessica Burns, Christopher P Wilding, Lukas Krasny, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 23, 2007
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines
George D Demetri, Robert S Benjamin, Charles D Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2018
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008
Jeremy Whelan, Marie-Cecile Le Deley, Uta Dirksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2019
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008
Uta Dirksen, Bernadette Brennan, Marie-Cécile Le Deley, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 151) with videos related to
Sort By:
Page
of 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2012
Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era
Philippe A Cassier, Elena Fumagalli, Piotr Rutkowski, et al.
The Lancet. Oncology
|
June 5, 2019
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial
Ian Judson, James P Morden, Lucy Kilburn, et al.
The Lancet. Oncology
|
March 13, 2014
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Ian Judson, Jaap Verweij, Hans Gelderblom, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 4, 2023
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022
Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2015
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
Nathalie Gaspar, Douglas S Hawkins, Uta Dirksen, et al.
The Lancet. Oncology
|
August 9, 2016
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
Mandy L Ballinger, David L Goode, Isabelle Ray-Coquard, et al.
Nature Communications
|
June 29, 2023
The proteomic landscape of soft tissue sarcomas
Jessica Burns, Christopher P Wilding, Lukas Krasny, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 23, 2007
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines
George D Demetri, Robert S Benjamin, Charles D Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2018
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008
Jeremy Whelan, Marie-Cecile Le Deley, Uta Dirksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2019
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008
Uta Dirksen, Bernadette Brennan, Marie-Cécile Le Deley, et al.
Page
of 16